bs-2606R [Primary Antibody]
IL17RA/CD217 Polyclonal Antibody
www.biossusa.com
[email protected]
800.501.7654 [DOMESTIC]
+1.781.569.5821 [INTERNATIONAL]
DATASHEET

Host: Rabbit

Target Protein: IL17RA/CD217

Immunogen Range: 240-280/866

Clonality: Polyclonal

Isotype: IgG

Entrez Gene: 23765

Swiss Prot: Q96F46

Source: KLH conjugated synthetic peptide derived from human IL17R

Purification: Purified by Protein A.

Storage Buffer: Aqueous buffered solution containing 1% BSA, 50% glycerol and 0.09% sodium azide.

Storage Condition: Store at -20°C for 12 months.

Background: Receptor for IL17A, IL17F and, in dimer with IL17RE, for IL17C. Binds its IL17A ligand with low affinity, suggesting that additional components are involved in IL17A-induced signaling.

Size: 100ul

Concentration: 1ug/ul

Applications: WB(1:300-1000)
IHC-P(1:200-400)
IF(IHC-P)(1:50-200)

Cross Reactive Species: Human
Mouse
Rat

For research use only. Not intended for diagnostic or therapeutic use.

PRODUCT SPECIFIC PUBLICATIONS
  • Tang, Wei‑Jing, et al. "Role of T helper 17 cytokines in the tumour immune inflammation response of patients with laryngeal squamous cell carcinoma." Oncology Letters.Read more>>
  • Tang et al. Role of T helper 17 cytokines in the tumour immune inflammation response of patients with laryngeal squamous cell carcinoma. (2017) Oncol.Lett. 14:561-568Read more>>
  • Bockerstett et al. Interleukin-17A Promotes Parietal Cell Atrophy by Inducing Apoptosis. (2018) Cell.Mol.Gastroenterol.Hepatol. 5:678-690.e1Read more>>
  • "Sun B et al. The interleukin-17 G-197A polymorphism is associated with cyclosporine metabolism and transplant rejection in liver transplant recipients. Pharmacogenomics. 2019 Feb 25."Read more>>
VALIDATION IMAGES

Lane 1: Raw264.7 cell lysates probed with IL17RA/CD217 Polyclonal Antibody, Unconjugated (bs-2606R) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.


Lane 1: Raw264.7 cell lysates probed with IL17RA/CD217 Polyclonal Antibody, Unconjugated (bs-2606R) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.